Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
European Journal of Immunology
|
January 31, 2022
Decoding the signaling profile of hematopoietic progenitor kinase 1 (HPK1) in innate immunity: A proteomic approach
Almke Bader, Michael Winkelmann, Ignasi Forné, et al.
Radiologie (Heidelberg, Germany)
|
April 28, 2025
[Primary imaging diagnostics of lymphomas]
Michael Winkelmann, Matthias Kassube, Johannes Rübenthaler, et al.
The New England Journal of Medicine
|
September 25, 2002
A poliomyelitis-like syndrome from West Nile virus infection
A Arturo Leis, Dobrivoje S Stokic, Jo Lynn Polk, et al.
Radiologie (Heidelberg, Germany)
|
December 9, 2025
[Pseudoprogression after start of immunotherapy]
Michael Winkelmann, Matthias Kassube, Philipp Linden, et al.
Diagnostics (Basel, Switzerland)
|
June 2, 2021
Sarcoid-Like Reaction in Non-Hodgkin's Lymphoma-A Diagnostic Challenge for Deauville Scoring on <sup>18</sup>F-FDG PET/CT Imaging
Michael Winkelmann, Kai Rejeski, Marion Subklewe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 21, 2020
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on <sup>18</sup>F-FDG PET/CT
Michael Winkelmann, Kai Rejeski, Marcus Unterrainer, et al.
Radiology and Oncology
|
December 1, 2023
Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM
Maria Ingenerf, Homeira Karim, Christoph Auernhammer, et al.
Radiology and Oncology
|
June 11, 2024
Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients
Homeira Karim, Michael Winkelmann, Freba Grawe, et al.
Biomedicines
|
October 27, 2022
Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters
Maria Ingenerf, Sophia Kiesl, Michael Winkelmann, et al.
Radiology and Oncology
|
April 13, 2024
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors
Maria Ingenerf, Christoph Auernhammer, Roberto Lorbeer, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
European Journal of Immunology
|
January 31, 2022
Decoding the signaling profile of hematopoietic progenitor kinase 1 (HPK1) in innate immunity: A proteomic approach
Almke Bader, Michael Winkelmann, Ignasi Forné, et al.
Radiologie (Heidelberg, Germany)
|
April 28, 2025
[Primary imaging diagnostics of lymphomas]
Michael Winkelmann, Matthias Kassube, Johannes Rübenthaler, et al.
The New England Journal of Medicine
|
September 25, 2002
A poliomyelitis-like syndrome from West Nile virus infection
A Arturo Leis, Dobrivoje S Stokic, Jo Lynn Polk, et al.
Radiologie (Heidelberg, Germany)
|
December 9, 2025
[Pseudoprogression after start of immunotherapy]
Michael Winkelmann, Matthias Kassube, Philipp Linden, et al.
Diagnostics (Basel, Switzerland)
|
June 2, 2021
Sarcoid-Like Reaction in Non-Hodgkin's Lymphoma-A Diagnostic Challenge for Deauville Scoring on <sup>18</sup>F-FDG PET/CT Imaging
Michael Winkelmann, Kai Rejeski, Marion Subklewe, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 21, 2020
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on <sup>18</sup>F-FDG PET/CT
Michael Winkelmann, Kai Rejeski, Marcus Unterrainer, et al.
Radiology and Oncology
|
December 1, 2023
Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM
Maria Ingenerf, Homeira Karim, Christoph Auernhammer, et al.
Radiology and Oncology
|
June 11, 2024
Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients
Homeira Karim, Michael Winkelmann, Freba Grawe, et al.
Biomedicines
|
October 27, 2022
Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters
Maria Ingenerf, Sophia Kiesl, Michael Winkelmann, et al.
Radiology and Oncology
|
April 13, 2024
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors
Maria Ingenerf, Christoph Auernhammer, Roberto Lorbeer, et al.
Page
of 5